• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 HPV 16 和 HPV 18 癌蛋白表达作为宫颈病变的替代诊断工具。

Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion.

机构信息

Department of Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

Department of Pathology, Hospital of Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

出版信息

Asian Pac J Cancer Prev. 2024 Feb 1;25(2):521-527. doi: 10.31557/APJCP.2024.25.2.521.

DOI:10.31557/APJCP.2024.25.2.521
PMID:38415538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11077110/
Abstract

OBJECTIVE

The study aimed to evaluate E6 and E7 oncoproteins of HPV16 and HPV18 expression in formalin - fixed paraffin embedded (FFPE) tissue in different grades of the cervical lesion and evaluate the potential use of E6 and E7 oncoproteins derived from HPV 16 and 18 as diagnostic protein biomarkers for triaging cervical lesions.

METHODOLOGY

A total of 102 FFPE cervical tissues were collected from 2 tertiary hospitals and immunohistochemical reactivity staining of E6 and E7 oncoproteins of HPV16 and HPV18 were evaluated using immunoreactive scoring (IRS) system and analysed statistically.

RESULT

The result showed an increased oncoprotein expression with the progression of cervical lesions. There is a statistically significant association between histology grade and HPV16/18-E6 expression (p = 0.028). However, there are no significant association of histological grade to HPV16-E7 immunoreactivity score (p = 0.264) and HPV18-E7 (p=0.080).

CONCLUSION

The immunohistochemical expression of HPV oncoproteins is a potential alternative diagnostic tool applicable in a low-resource laboratory setting. The advantage of the histochemical evaluation is that this method is simpler to apply and less expensive in comparison to in situ mRNA hybridization. Nevertheless, our study also found that antibodies against HPV that are commercially available suffer quite substantial specificity issues such as background staining and inconsistency between different batches. Hence, the utilization of antibody-based staining warrants stringent quality control.

摘要

目的

本研究旨在评估 HPV16 和 HPV18 的 E6 和 E7 癌蛋白在不同宫颈病变分级的福尔马林固定石蜡包埋(FFPE)组织中的表达,并评估 HPV16 和 18 的 E6 和 E7 癌蛋白作为宫颈病变分流的诊断蛋白生物标志物的潜在用途。

方法

从 2 家 3 级医院共收集了 102 例 FFPE 宫颈组织,使用免疫反应评分(IRS)系统评估 HPV16 和 HPV18 的 E6 和 E7 癌蛋白的免疫反应性,并进行统计学分析。

结果

结果表明,随着宫颈病变的进展,癌蛋白表达增加。组织学分级与 HPV16/18-E6 表达之间存在统计学显著关联(p=0.028)。然而,HPV16-E7 免疫反应评分(p=0.264)和 HPV18-E7 与组织学分级之间无显著相关性(p=0.080)。

结论

HPV 癌蛋白的免疫组织化学表达是一种潜在的替代诊断工具,适用于资源有限的实验室环境。与原位 mRNA 杂交相比,组织化学评估的优势在于该方法更简单且更经济。然而,我们的研究还发现,市售的针对 HPV 的抗体存在相当大的特异性问题,例如背景染色和不同批次之间的不一致性。因此,基于抗体的染色的利用需要严格的质量控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/dcd4cddd2063/APJCP-25-521-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/5fa3b13dbd98/APJCP-25-521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/1a1fb3f08f27/APJCP-25-521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/e4cd4fdd2f5d/APJCP-25-521-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/dcd4cddd2063/APJCP-25-521-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/5fa3b13dbd98/APJCP-25-521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/1a1fb3f08f27/APJCP-25-521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/e4cd4fdd2f5d/APJCP-25-521-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d4e/11077110/dcd4cddd2063/APJCP-25-521-g004.jpg

相似文献

1
Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion.评估 HPV 16 和 HPV 18 癌蛋白表达作为宫颈病变的替代诊断工具。
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):521-527. doi: 10.31557/APJCP.2024.25.2.521.
2
TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.维吾尔族女性子宫颈病变中TLR9的表达与宫颈癌进展及人乳头瘤病毒16 E6和E7癌蛋白在体外的选择性沉默相关。
Asian Pac J Cancer Prev. 2014;15(14):5867-72. doi: 10.7314/apjcp.2014.15.14.5867.
3
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.通过 CRISPR/Cas13a 系统切割人乳头瘤病毒 E6/E7 mRNA 抑制人宫颈癌细胞的体外和体内生长。
Antiviral Res. 2020 Jun;178:104794. doi: 10.1016/j.antiviral.2020.104794. Epub 2020 Apr 14.
4
Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.蜜蜂毒液通过对宫颈癌细胞系中HPV E6和E7表达的差异性抑制而具有抗癌和抗病毒作用。
Oncol Rep. 2015 Apr;33(4):1675-82. doi: 10.3892/or.2015.3760. Epub 2015 Jan 28.
5
Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.人乳头瘤病毒E6和E7癌蛋白检测用于诊断宫颈上皮内瘤变和宫颈癌的可行性研究
J Int Med Res. 2018 Mar;46(3):1033-1042. doi: 10.1177/0300060517736913. Epub 2018 Jan 11.
6
Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.锌指核酸酶靶向人乳头瘤病毒 E7 癌基因诱导 HPV16/18 阳性宫颈癌细胞中 E7 的破坏和转化表型。
Clin Cancer Res. 2014 Dec 15;20(24):6495-503. doi: 10.1158/1078-0432.CCR-14-0250. Epub 2014 Oct 21.
7
Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia.沙特阿拉伯妇女中 HPV16 和 HPV18 的 E6、E7 和 L1 基因的遗传变异性。
Viruses. 2022 Dec 30;15(1):109. doi: 10.3390/v15010109.
8
Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.人乳头瘤病毒16/18 E6和E7癌蛋白在HIV阳性女性高级别宫颈鳞状上皮内病变中的免疫表达
Genet Mol Res. 2016 Feb 19;15(1):gmr7220. doi: 10.4238/gmr.15017220.
9
Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis.高危型 HPV 早期癌蛋白(E6 和 E7)血清学标志物在宫颈癌检测中的应用:系统评价和荟萃分析。
J Med Virol. 2023 Jan;95(1):e27900. doi: 10.1002/jmv.27900. Epub 2022 Jun 9.
10
A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.一种新型的 MLL5 异构体,对激活 HPV16/18 相关宫颈癌中的 E6 和 E7 转录至关重要。
Cancer Res. 2011 Nov 1;71(21):6696-707. doi: 10.1158/0008-5472.CAN-11-1271. Epub 2011 Sep 9.

本文引用的文献

1
Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions.宫颈病变中人类乳头瘤病毒16型E7癌蛋白的免疫组织化学检测
J Cancer. 2021 Oct 20;12(23):7130-7137. doi: 10.7150/jca.60554. eCollection 2021.
2
The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.HPV E6/E7 mRNA 定量分析在鉴别高级别宫颈鳞状上皮内病变与低级别宫颈鳞状上皮内病变中的价值。
J Virol Methods. 2021 Mar;289:114014. doi: 10.1016/j.jviromet.2020.114014. Epub 2020 Nov 11.
3
HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review.
用于检测高级别宫颈上皮内瘤变(CIN2+)的人乳头瘤病毒E6/E7信使核糖核酸检测:一项系统综述
Infect Agent Cancer. 2020 Feb 7;15:9. doi: 10.1186/s13027-020-0278-x. eCollection 2020.
4
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy.人乳头瘤病毒E6和E7:宫颈癌的标志及治疗靶点
Front Microbiol. 2020 Jan 21;10:3116. doi: 10.3389/fmicb.2019.03116. eCollection 2019.
5
Immunohistochemical detection of E7 human papillomavirus protein in pre‑malignant and malignant lesions of the uterine cervix.免疫组织化学法检测子宫颈癌前病变及恶性病变中人乳头瘤病毒 E7 蛋白的表达
Mol Med Rep. 2018 Oct;18(4):3949-3956. doi: 10.3892/mmr.2018.9416. Epub 2018 Aug 22.
6
Understanding the HPV integration and its progression to cervical cancer.了解 HPV 整合及其向宫颈癌的进展。
Infect Genet Evol. 2018 Jul;61:134-144. doi: 10.1016/j.meegid.2018.03.003. Epub 2018 Mar 6.
7
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
8
Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.宫颈脱落细胞中人乳头瘤病毒(HPV)E6/E7 mRNA检测:HPV阳性女性的一种潜在分流方法
J Zhejiang Univ Sci B. 2017;18(3):256-262. doi: 10.1631/jzus.B1600288.
9
Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.宫颈癌中E6/E7人乳头瘤病毒癌蛋白染色的免疫组织化学评估
Anticancer Res. 2016 Jun;36(6):3195-8.
10
Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.人乳头瘤病毒16/18 E6和E7癌蛋白在HIV阳性女性高级别宫颈鳞状上皮内病变中的免疫表达
Genet Mol Res. 2016 Feb 19;15(1):gmr7220. doi: 10.4238/gmr.15017220.